Jilin Province Huinan Changlong Bio-pharmacy Company Limited - Laporan Laba Rugi (TTM)

Jilin Province Huinan Changlong Bio-pharmacy Company Limited
HK ˙ SEHK
HK$ 2.11 0.00 (0.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Jilin Province Huinan Changlong Bio-pharmacy Company Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 614 622 641 638 655 705 750 781 825 842 791 860 841 842 896 839 886 881 904 927
Change (%) 1.29 3.02 -0.48 2.74 7.63 6.33 4.18 5.60 1.98 -6.04 8.75 -2.20 0.06 6.42 -6.31 5.58 -0.53 2.60 2.53
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 96 91 95 110 118 126 134 143 156 194 204 244 251 257 255 206 213 196 196 195
Change (%) -6.11 5.28 15.80 7.35 6.49 6.46 6.76 8.60 24.27 5.30 19.58 3.01 2.57 -1.07 -19.17 3.62 -8.18 -0.20 -0.20
% of Revenue 15.70 14.55 14.87 17.30 18.08 17.89 17.91 18.35 18.87 23.00 25.77 28.34 29.85 30.60 28.45 24.54 24.09 22.23 21.63 21.05
Gross Operating Profit 518 532 546 528 537 579 616 638 669 648 587 616 590 584 641 633 672 685 709 732
Change (%) 2.67 2.63 -3.33 1.78 7.88 6.30 3.61 4.93 -3.20 -9.42 4.98 -4.26 -1.00 9.72 -1.20 6.22 1.90 3.40 3.29
% of Revenue 84.30 85.45 85.13 82.70 81.92 82.11 82.09 81.65 81.13 77.00 74.23 71.66 70.15 69.40 71.55 75.46 75.91 77.77 78.37 78.95
SG&A 385 428 425 409 400 453 473 487 543 510 462 466 434 449 478 492 530 522 537 552
Change (%) 11.36 -0.81 -3.69 -2.26 13.32 4.31 3.04 11.46 -6.10 -9.47 0.86 -6.72 3.38 6.53 2.95 7.59 -1.42 2.89 2.81
% of Revenue 62.62 68.84 66.29 64.15 61.03 64.25 63.03 62.35 65.81 60.59 58.38 54.14 51.64 53.35 53.40 58.68 59.80 59.26 59.43 59.60
R&D
Change (%)
% of Revenue
OpEx 468 508 520 523 521 565 593 611 679 684 605 687 641 681 738 658 735 697 721 746
Change (%) 8.58 2.36 0.54 -0.32 8.42 5.05 3.05 11.11 0.62 -11.44 13.45 -6.64 6.18 8.42 -10.91 11.70 -5.19 3.57 3.45
% of Revenue 76.13 81.61 81.09 81.93 79.49 80.07 79.10 78.25 82.33 81.23 76.56 79.87 76.25 80.91 82.43 78.39 82.93 79.05 79.80 80.51
Operating Income 147 114 121 115 134 141 157 170 146 158 185 173 200 161 157 181 151 185 183 181
Change (%) -21.96 5.91 -4.88 16.64 4.59 11.48 8.43 -14.20 8.34 17.32 -6.62 15.40 -19.58 -2.07 15.25 -16.62 22.13 -1.08 -1.10
% of Revenue 23.87 18.39 18.91 18.07 20.51 19.93 20.90 21.75 17.67 18.77 23.44 20.13 23.75 19.09 17.57 21.61 17.07 20.95 20.20 19.49
Interest Expense -1 -1 -0 -0 -0 -0 -1 -1 -1 -0 -0 -2 -2 -1 -1 -0 -2 -2 -2
Change (%) -2.99 -75.32 28.98 -6.17 61.50 105.81 11.44 5.32 -42.60 -95.18 6,986.96 -1.96 -67.77 73.88 1,589.17 3.16 3.06
% of Revenue -0.12 -0.11 -0.03 -0.04 -0.03 -0.05 -0.09 -0.10 -0.10 -0.06 -0.00 -0.19 -0.19 -0.06 -0.10 -0.01 -0.23 -0.23 -0.23
Net Income 140 127 133 124 140 143 157 172 151 194 212 197 222 148 148 172 159 184 184 183
Change (%) -9.37 4.93 -6.74 13.44 1.98 9.43 9.42 -12.00 28.21 9.70 -7.15 12.70 -33.30 -0.17 16.01 -7.26 15.75 -0.35 -0.35
% of Revenue 22.73 20.34 20.72 19.41 21.44 20.31 20.90 21.95 18.29 23.00 26.85 22.93 26.42 17.61 16.52 20.46 17.97 20.91 20.31 19.74

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista